Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Charles Schwab Corp. | 18 | 3 | 4 | 1 | €68.64 | €73.30 | 6.784% |
| Boston Scientific | 49 | 0 | 4 | 0 | €71.50 | €73.64 | 2.992% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 4 | 0 | €14.48 | €24.13 | 66.723% |
| Neurocrine Bioscience | 31 | 0 | 4 | 0 | €125.00 | €140.60 | 12.483% |
| Williams-Sonoma Inc. | 18 | 9 | 4 | 0 | €270.90 | €246.17 | -9.129% |
| MacroGenics Inc. | 13 | 0 | 4 | 0 | €4.20 | €12.42 | 195.685% |
| Nexstar Broadcast.A | 11 | 1 | 4 | 1 | €145.70 | €200.24 | 37.432% |
| Transdigm Group | 27 | 0 | 4 | 0 | €1,222.0 | €1,284.0 | 5.070% |
| Autodesk Inc. | 40 | 1 | 4 | 0 | €200.40 | €244.24 | 21.875% |
| Arrowhead Pharmaceuticals Inc. | 16 | 2 | 4 | 0 | €22.02 | €54.74 | 148.569% |
| ConocoPhillips | 29 | 0 | 4 | 0 | €104.90 | €134.14 | 27.875% |
| Abercrombie + Fitch A | 15 | 0 | 3 | 0 | €164.60 | €198.98 | 20.889% |
| McEwen Mining Inc. | 6 | 1 | 3 | 0 | €9.95 | €13.89 | 39.583% |
| Vivoryon Therapeutics N.V. | 4 | 2 | 3 | 2 | €2.51 | €31.00 | 1135.060% |
| Triumph Group Inc. | 12 | 2 | 3 | 0 | €13.80 | €17.47 | 26.607% |
| Infinera Corp. | 9 | 1 | 3 | 0 | €5.05 | €7.59 | 50.384% |
| Spectrum Brands Holdings, Inc | 7 | 1 | 3 | 0 | €82.00 | €92.72 | 13.073% |
| Norfolk Southern Corp. | 23 | 1 | 3 | 0 | €208.00 | €249.81 | 20.100% |
| Gaming & Leisure Properties | 13 | 0 | 3 | 0 | €40.30 | €47.90 | 18.853% |
| Skechers U.s.a. Inc. | 20 | 0 | 3 | 0 | €67.62 | €66.33 | -1.902% |
| Equinix Inc. | 12 | 1 | 3 | 0 | €698.60 | €839.21 | 20.128% |
| Hannon Armstrong | 10 | 1 | 3 | 0 | €29.25 | €32.21 | 10.132% |
| Palomar Holdings Inc | 10 | 0 | 3 | 0 | €79.50 | €83.17 | 4.618% |
| Lincoln Electric Holdings | 8 | 1 | 3 | 0 | €172.00 | €227.90 | 32.500% |
| Dolby Laboratories Inc. A | 13 | 0 | 3 | 0 | €73.50 | €90.49 | 23.120% |